769 860
silodosin in men with LUTS suggestive of BPH: pooled analysis of
three randomized, placebo-controlled, double-blind phase III stud-
ies. World J Urol 2014;32:1119–25.
[23]
Chapple CR, Montorsi F, Tammela TL, et al. Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active controlled clinical trial per- formed in Europe. Eur Urol 2011;59:342–52.[24]
Simaioforidis V, Papatsoris AG, Chrisofos M, Chrisafis M, Koritsiadis S, Deliveliotis C. Tamsulosin versus transurethral resection of the prostate: effect on nocturia as a result of benign prostatic hyper- plasia. Int J Urol 2011;18:243–8.[25]
Ahmed AF, Maarouf A, Shalaby E, Gabr AH, Shahin A, Ghobish A. The impact of adding low dose oral desmopressin therapy to tamsulosin therapy for treatment of nocturia owing to benign prostatic hyper- plasia. World J Urol 2015;33:649–57.[26]
Ichihara K, Masumori N, Fukuta F, Tsukamoto T, Iwasawa A, Tanaka Y. A randomized controlled study of the efficacy of tamsulosin monotherapy and its combination with mirabegron for overactive bladder induced by benign prostatic obstruction. J Urol 2015;193:921–6.
[27]
Oelke M, Roehrborn CG, D’Ancona C, Wilson TH, Castro R, Manyak M. Nocturia improvement in the combination of Avodart and tamsulosin (CombAT) study. World J Urol 2014;32:1133–40.[28]
Kaplan SA, Roehrborn CG, Dmochowski R, Rovner ES, Wang JT, Guan Z. Tolterodine extended release improves overactive bladder symp- toms in men with overactive bladder and nocturia. Urology 2006;68:328–32.[29]
Rackley R, Weiss JP, Rovner ES, Wang JT, Guan Z. Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal mic- turitions in patients with overactive bladder and nocturia. Urology 2006;67:731–6, discussion 736.[30]
Weiss JP, Jumadilova Z, Johnson TM, et al. Efficacy and safety of flexible dose fesoterodine in men and women with overactive bladder symptoms including nocturnal urinary urgency. J Urol 2013;189:1396–401.[31]
Yokoyama O, Hiro S, Hotta S, Mogami S, Yamagami H. Efficacy of fesoterodine on nocturia and quality of sleep in Asian patients with overactive bladder. Urology 2014;83:750–5.[32]
Yokoyama O, Yamaguchi O, Kakizaki H, et al. Efficacy of solifenacin on nocturia in Japanese patients with overactive bladder: Impact on sleep evaluated by bladder diary. J Urol 2011;186:170–4.[33]
Gotoh M, Yokoyama O, Nishizawa O. Propiverine hydrochloride in Japanese patients with overactive bladder: a randomized, double- blind, placebo-controlled trial. Int J Urol 2011;18:365–73.[34]
Yamaguchi O, Marui E, Kakizaki H, et al. Randomized, double-blind, placebo- and propiverine-controlled trial of the once daily anti- muscarinic agent solifenacin in Japanese patients with overactive bladder. BJU Int 2007;100:579–87.[35]
Chapple CR, Dvorak V, Radziszewski P, et al. A phase II dose-ranging study of mirabegron in patients with overactive bladder. Int Uro- gynecol J 2013;24:1447–58.[36]
Oelke M, Roehrborn CG, D’Ancona C, Wilson TH, Castro R, Manyak M. Impact of dutasteride on nocturia in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH): a pooled analysis of three phase III studies. World J Urol 2014;32:1141–7.
[37]
Johnson ITM, Burrows PK, Kusek JW, et al. The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia. J Urol 2007;178:2045–51.[38]
Matthiesen TB, Rittig S, Djurhuus JC. Changes in nocturia from medical treatment of benign prostatic hyperplasia: Secondary analysis of the Department of Veterans Affairs Cooperative Study Trial. J Urol 2003;170:145–8.[39]
Oelke M, Weiss JP, Mamoulakis C, Cox D, Ruff D, Viktrup L. Effects of tadalafil on nighttime voiding (nocturia) in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a post hoc analysis of pooled data from four randomized, placebo-con- trolled clinical studies. World J Urol 2014;32:1127–32.[40]
Fujikawa K, Kasahara M, Matsui Y, Takeuchi H. Human atrial natriuretic peptide is a useful criterion in treatment of nocturia. Scand J Urol Nephrol 2001;35:310–3.[41]
Pedersen PA, Johansen B. Prophylactic treatment of adult nocturia with bumetanide. Br J Urol 1988;62:145–7.[42]
Reynard JM, Cannon A, Yang Q, Abrams P. A novel therapy for nocturnal polyuria: A double-blind randomized trial of frusemide against placebo. Br J Urol 1998;81:215–8.[43]
Fu FG, Lavery HJ, Wu DL. Reducing nocturia in the elderly: A randomized placebo-controlled trial of staggered furosemide and desmopressin. Neurourol Urodyn 2011;30:437–52.[44]
Addla SK, Adeyoju AB, Neilson D, O’Reilly P. Diclofenac for treat- ment of nocturia caused by nocturnal polyuria: a prospective, randomised, double-blind, placebo-controlled crossover study. Eur Urol 2006;49:720–5.[45]
Falahatkar S, Mokhtari G, Pourreza F, Asgari SA, Kamran AN. Cel- ecoxib for treatment of nocturia caused by benign prostatic hyper- plasia: a prospective, randomized, double-blind, placebo- controlled study. Urology 2008;72:813–6.
[46]
Gorgel SN, Sefik E, Kose O, Olgunelma V, Sahin E. The effect of combined therapy with tamsulosin hydrochloride and meloxicam in patients with benign prostatic hyperplasia symptoms and impact on nocturia and sleep quality. Int Braz J Urol 2013;39: 657–62.
[47]
Shin HI, Kim BH, Chang HS, Park CH, Kim CI. Long-term effect of loxoprofen sodium on nocturia in patients with benign prostatic hyperplasia. Korean J Urol 2011;52:265–8.[48]
Sigurdsson S, Geirsson G, Gudmundsdottir H, Egilsdottir PB, Gudb- jarnason S. A parallel, randomized, double-blind, placebo-con- trolled study to investigate the effect of SagaPro on nocturia in men. Scand J Urol 2013;47:26–32.[49]
Yoshimura K, Shimizu Y, Masui K, et al. Furosemide versus gosha- jinki-gan, a blended herbal medicine, for nocturnal polyuria: a randomized crossover trial. Low Urin Tract Symptoms 2012;4: 77–81.[50]
Drake MJ, Mills IW, Noble JG. Melatonin pharmacotherapy for nocturia in men with benign prostatic enlargement. J Urol 2004;171:1199–202.[51]
Van DijkMM, Wijkstra H, Debruyne FM, De La Rosette JJ, Michel MC. The role of nocturia in the quality of life of men with lower urinary tract symptoms. BJU Int 2010;105:1141–6.E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) 7 5 7 – 7 6 9
769